HEADER OXIDOREDUCTASE 30-OCT-06 2NQ8 TITLE MALARIAL ENOYL ACYL ACP REDUCTASE BOUND WITH INH-NAD ADDUCT COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL-ACYL CARRIER REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ENOYL-ACP REDUCTASE; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: ENOYL-ACYL CARRIER REDUCTASE; COMPND 8 CHAIN: C, D; COMPND 9 SYNONYM: ENOYL-ACP REDUCTASE; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_COMMON: MALARIA PARASITE P. FALCIPARUM; SOURCE 4 ORGANISM_TAXID: 5833; SOURCE 5 GENE: FABI; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 10 ORGANISM_COMMON: MALARIA PARASITE P. FALCIPARUM; SOURCE 11 ORGANISM_TAXID: 5833; SOURCE 12 GENE: FABI; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PFENR; INH; MALARIA, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR J.S.FREUNDLICH,M.YU,E.LUCUMI,M.KUO,H.C.TSAI,J.C.VALDERRAMOS, AUTHOR 2 L.KARAGYOZOV,W.R.JACOBS JR.,G.A.SCHIEHSER,D.A.FIDOCK,D.P.JACOBUS, AUTHOR 3 J.C.SACCHETTINI REVDAT 6 30-AUG-23 2NQ8 1 REMARK REVDAT 5 13-JUL-11 2NQ8 1 VERSN REVDAT 4 24-FEB-09 2NQ8 1 VERSN REVDAT 3 20-NOV-07 2NQ8 1 JRNL REVDAT 2 31-JUL-07 2NQ8 1 JRNL REVDAT 1 17-JUL-07 2NQ8 0 JRNL AUTH J.S.FREUNDLICH,F.WANG,H.C.TSAI,M.KUO,H.M.SHIEH,J.W.ANDERSON, JRNL AUTH 2 L.J.NKRUMAH,J.C.VALDERRAMOS,M.YU,T.R.KUMAR,S.G.VALDERRAMOS, JRNL AUTH 3 W.R.JACOBS,G.A.SCHIEHSER,D.P.JACOBUS,D.A.FIDOCK, JRNL AUTH 4 J.C.SACCHETTINI JRNL TITL X-RAY STRUCTURAL ANALYSIS OF PLASMODIUM FALCIPARUM ENOYL JRNL TITL 2 ACYL CARRIER PROTEIN REDUCTASE AS A PATHWAY TOWARD THE JRNL TITL 3 OPTIMIZATION OF TRICLOSAN ANTIMALARIAL EFFICACY JRNL REF J.BIOL.CHEM. V. 282 25436 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17567585 JRNL DOI 10.1074/JBC.M701813200 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 70.15 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.5 REMARK 3 NUMBER OF REFLECTIONS : 24177 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2379 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4578 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 104 REMARK 3 SOLVENT ATOMS : 160 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.59000 REMARK 3 B22 (A**2) : 2.59000 REMARK 3 B33 (A**2) : -5.17900 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.26 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.36 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2NQ8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-NOV-06. REMARK 100 THE DEPOSITION ID IS D_1000040169. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 121 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : BRUKER AXS MICROSTAR REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRUKER SMART 2000 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : PROTEUM PLUS PLUS REMARK 200 DATA SCALING SOFTWARE : PROTEUM PLUS PLUS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24589 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 70.150 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.63 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 15.18 REMARK 200 R MERGE FOR SHELL (I) : 0.27400 REMARK 200 R SYM FOR SHELL (I) : 0.27700 REMARK 200 FOR SHELL : 0.710 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1NHD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.76 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.4M (NH4)2SO4, 0.1M MES ( PH 5.6), REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.42250 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 65.94950 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 65.94950 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 62.13375 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 65.94950 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 65.94950 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 20.71125 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 65.94950 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 65.94950 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 62.13375 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 65.94950 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 65.94950 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 20.71125 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 41.42250 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A TERAMER GENERATED FROM THE REMARK 300 DIMER IN THE ASYMMETRIC UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: OCTAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 35510 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 39130 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -222.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 131.89900 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 131.89900 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 41.42250 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 132 -56.94 -29.24 REMARK 500 LYS A 155 14.93 -53.55 REMARK 500 ALA A 169 6.73 -69.00 REMARK 500 LYS A 185 -35.95 -36.57 REMARK 500 ASN A 188 -70.51 -43.60 REMARK 500 LEU A 226 -55.92 -27.70 REMARK 500 HIS A 268 -13.44 -49.84 REMARK 500 SER A 317 -106.65 -98.41 REMARK 500 ARG A 318 -38.96 -149.38 REMARK 500 ASN A 324 101.17 29.57 REMARK 500 ASP B 107 164.70 166.50 REMARK 500 ASP B 154 -59.90 -23.65 REMARK 500 LYS B 155 37.10 -67.67 REMARK 500 ASP B 156 -23.67 64.93 REMARK 500 LYS B 157 155.43 -45.85 REMARK 500 MET B 159 142.71 -30.21 REMARK 500 ALA B 169 2.32 -65.73 REMARK 500 ASN B 210 15.75 -142.38 REMARK 500 ASN B 324 101.45 53.83 REMARK 500 THR C 367 142.43 49.04 REMARK 500 ASP C 414 29.69 -148.87 REMARK 500 PHE C 421 -72.33 -94.28 REMARK 500 THR D 367 148.92 51.98 REMARK 500 ASP D 414 35.24 -150.40 REMARK 500 PRO D 423 -141.62 -67.99 REMARK 500 ASP D 424 -74.06 -144.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZID B 450 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZID A 550 DBREF 2NQ8 A 97 325 UNP Q9BH77 Q9BH77_PLAFA 97 325 DBREF 2NQ8 B 97 325 UNP Q9BH77 Q9BH77_PLAFA 97 325 DBREF 2NQ8 C 366 425 UNP Q9BH77 Q9BH77_PLAFA 366 425 DBREF 2NQ8 D 366 425 UNP Q9BH77 Q9BH77_PLAFA 366 425 SEQRES 1 A 229 GLU ASP ILE CYS PHE ILE ALA GLY ILE GLY ASP THR ASN SEQRES 2 A 229 GLY TYR GLY TRP GLY ILE ALA LYS GLU LEU SER LYS ARG SEQRES 3 A 229 ASN VAL LYS ILE ILE PHE GLY ILE TRP PRO PRO VAL TYR SEQRES 4 A 229 ASN ILE PHE MET LYS ASN TYR LYS ASN GLY LYS PHE ASP SEQRES 5 A 229 ASN ASP MET ILE ILE ASP LYS ASP LYS LYS MET ASN ILE SEQRES 6 A 229 LEU ASP MET LEU PRO PHE ASP ALA SER PHE ASP THR ALA SEQRES 7 A 229 ASN ASP ILE ASP GLU GLU THR LYS ASN ASN LYS ARG TYR SEQRES 8 A 229 ASN MET LEU GLN ASN TYR THR ILE GLU ASP VAL ALA ASN SEQRES 9 A 229 LEU ILE HIS GLN LYS TYR GLY LYS ILE ASN MET LEU VAL SEQRES 10 A 229 HIS SER LEU ALA ASN ALA LYS GLU VAL GLN LYS ASP LEU SEQRES 11 A 229 LEU ASN THR SER ARG LYS GLY TYR LEU ASP ALA LEU SER SEQRES 12 A 229 LYS SER SER TYR SER LEU ILE SER LEU CYS LYS TYR PHE SEQRES 13 A 229 VAL ASN ILE MET LYS PRO GLN SER SER ILE ILE SER LEU SEQRES 14 A 229 THR TYR HIS ALA SER GLN LYS VAL VAL PRO GLY TYR GLY SEQRES 15 A 229 GLY GLY MET SER SER ALA LYS ALA ALA LEU GLU SER ASP SEQRES 16 A 229 THR ARG VAL LEU ALA TYR HIS LEU GLY ARG ASN TYR ASN SEQRES 17 A 229 ILE ARG ILE ASN THR ILE SER ALA GLY PRO LEU LYS SER SEQRES 18 A 229 ARG ALA ALA THR ALA ILE ASN LYS SEQRES 1 B 229 GLU ASP ILE CYS PHE ILE ALA GLY ILE GLY ASP THR ASN SEQRES 2 B 229 GLY TYR GLY TRP GLY ILE ALA LYS GLU LEU SER LYS ARG SEQRES 3 B 229 ASN VAL LYS ILE ILE PHE GLY ILE TRP PRO PRO VAL TYR SEQRES 4 B 229 ASN ILE PHE MET LYS ASN TYR LYS ASN GLY LYS PHE ASP SEQRES 5 B 229 ASN ASP MET ILE ILE ASP LYS ASP LYS LYS MET ASN ILE SEQRES 6 B 229 LEU ASP MET LEU PRO PHE ASP ALA SER PHE ASP THR ALA SEQRES 7 B 229 ASN ASP ILE ASP GLU GLU THR LYS ASN ASN LYS ARG TYR SEQRES 8 B 229 ASN MET LEU GLN ASN TYR THR ILE GLU ASP VAL ALA ASN SEQRES 9 B 229 LEU ILE HIS GLN LYS TYR GLY LYS ILE ASN MET LEU VAL SEQRES 10 B 229 HIS SER LEU ALA ASN ALA LYS GLU VAL GLN LYS ASP LEU SEQRES 11 B 229 LEU ASN THR SER ARG LYS GLY TYR LEU ASP ALA LEU SER SEQRES 12 B 229 LYS SER SER TYR SER LEU ILE SER LEU CYS LYS TYR PHE SEQRES 13 B 229 VAL ASN ILE MET LYS PRO GLN SER SER ILE ILE SER LEU SEQRES 14 B 229 THR TYR HIS ALA SER GLN LYS VAL VAL PRO GLY TYR GLY SEQRES 15 B 229 GLY GLY MET SER SER ALA LYS ALA ALA LEU GLU SER ASP SEQRES 16 B 229 THR ARG VAL LEU ALA TYR HIS LEU GLY ARG ASN TYR ASN SEQRES 17 B 229 ILE ARG ILE ASN THR ILE SER ALA GLY PRO LEU LYS SER SEQRES 18 B 229 ARG ALA ALA THR ALA ILE ASN LYS SEQRES 1 C 60 TYR THR PHE ILE ASP TYR ALA ILE GLU TYR SER GLU LYS SEQRES 2 C 60 TYR ALA PRO LEU ARG GLN LYS LEU LEU SER THR ASP ILE SEQRES 3 C 60 GLY SER VAL ALA SER PHE LEU LEU SER ARG GLU SER ARG SEQRES 4 C 60 ALA ILE THR GLY GLN THR ILE TYR VAL ASP ASN GLY LEU SEQRES 5 C 60 ASN ILE MET PHE LEU PRO ASP ASP SEQRES 1 D 60 TYR THR PHE ILE ASP TYR ALA ILE GLU TYR SER GLU LYS SEQRES 2 D 60 TYR ALA PRO LEU ARG GLN LYS LEU LEU SER THR ASP ILE SEQRES 3 D 60 GLY SER VAL ALA SER PHE LEU LEU SER ARG GLU SER ARG SEQRES 4 D 60 ALA ILE THR GLY GLN THR ILE TYR VAL ASP ASN GLY LEU SEQRES 5 D 60 ASN ILE MET PHE LEU PRO ASP ASP HET ZID A 550 52 HET ZID B 450 52 HETNAM ZID ISONICOTINIC-ACETYL-NICOTINAMIDE-ADENINE DINUCLEOTIDE FORMUL 5 ZID 2(C27 H30 N8 O15 P2) FORMUL 7 HOH *160(H2 O) HELIX 1 1 GLY A 110 ARG A 122 1 13 HELIX 2 2 TRP A 131 ASN A 144 1 14 HELIX 3 3 PHE A 147 MET A 151 1 5 HELIX 4 4 THR A 173 ILE A 177 5 5 HELIX 5 5 ASP A 178 ASN A 183 1 6 HELIX 6 6 THR A 194 GLY A 207 1 14 HELIX 7 7 ASP A 225 THR A 229 5 5 HELIX 8 8 SER A 230 SER A 242 1 13 HELIX 9 9 SER A 242 VAL A 253 1 12 HELIX 10 10 TYR A 267 GLN A 271 5 5 HELIX 11 11 GLY A 280 TYR A 303 1 24 HELIX 12 12 GLY B 110 ARG B 122 1 13 HELIX 13 13 TRP B 131 PRO B 133 5 3 HELIX 14 14 VAL B 134 ASN B 144 1 11 HELIX 15 15 PHE B 147 MET B 151 5 5 HELIX 16 16 THR B 173 ILE B 177 5 5 HELIX 17 17 ASP B 178 ASN B 184 1 7 HELIX 18 18 THR B 194 GLY B 207 1 14 HELIX 19 19 ASP B 225 THR B 229 5 5 HELIX 20 20 SER B 230 SER B 242 1 13 HELIX 21 21 SER B 242 VAL B 253 1 12 HELIX 22 22 TYR B 267 GLN B 271 5 5 HELIX 23 23 GLY B 280 ASN B 304 1 25 HELIX 24 24 SER B 317 ILE B 323 1 7 HELIX 25 25 TYR C 366 ALA C 380 1 15 HELIX 26 26 LEU C 387 SER C 400 1 14 HELIX 27 27 ARG C 401 ARG C 404 5 4 HELIX 28 28 GLY C 416 MET C 420 5 5 HELIX 29 29 TYR D 366 ALA D 380 1 15 HELIX 30 30 LEU D 387 SER D 400 1 14 HELIX 31 31 ARG D 401 ARG D 404 5 4 HELIX 32 32 GLY D 416 MET D 420 5 5 SHEET 1 A 7 ILE A 161 PRO A 166 0 SHEET 2 A 7 LYS A 125 ILE A 130 1 N ILE A 130 O LEU A 165 SHEET 3 A 7 ILE A 99 ILE A 105 1 N ILE A 102 O GLY A 129 SHEET 4 A 7 ILE A 209 HIS A 214 1 O VAL A 213 N ALA A 103 SHEET 5 A 7 MET A 256 THR A 266 1 O ILE A 263 N HIS A 214 SHEET 6 A 7 ARG A 306 ALA A 312 1 O ILE A 310 N SER A 264 SHEET 7 A 7 THR C 410 VAL C 413 1 O ILE C 411 N THR A 309 SHEET 1 B 2 ILE A 152 ILE A 153 0 SHEET 2 B 2 LYS A 157 LYS A 158 -1 O LYS A 157 N ILE A 153 SHEET 1 C 7 ILE B 161 PRO B 166 0 SHEET 2 C 7 LYS B 125 ILE B 130 1 N ILE B 130 O LEU B 165 SHEET 3 C 7 ILE B 99 ALA B 103 1 N ILE B 102 O GLY B 129 SHEET 4 C 7 ILE B 209 HIS B 214 1 O VAL B 213 N PHE B 101 SHEET 5 C 7 MET B 256 THR B 266 1 O ILE B 263 N HIS B 214 SHEET 6 C 7 ARG B 306 ALA B 312 1 O ILE B 310 N THR B 266 SHEET 7 C 7 THR D 410 VAL D 413 1 O ILE D 411 N THR B 309 SITE 1 AC1 30 GLY B 104 ILE B 105 GLY B 106 GLY B 110 SITE 2 AC1 30 TYR B 111 TRP B 131 PHE B 167 ASP B 168 SITE 3 AC1 30 ALA B 169 SER B 215 LEU B 216 ALA B 217 SITE 4 AC1 30 ASN B 218 LEU B 265 THR B 266 TYR B 267 SITE 5 AC1 30 LYS B 285 ALA B 312 GLY B 313 PRO B 314 SITE 6 AC1 30 LEU B 315 SER B 317 ALA B 319 HOH B 451 SITE 7 AC1 30 HOH B 462 HOH B 481 HOH B 493 HOH B 499 SITE 8 AC1 30 PHE D 368 ALA D 372 SITE 1 AC2 28 GLY A 104 ILE A 105 GLY A 106 GLY A 110 SITE 2 AC2 28 TYR A 111 TRP A 131 PHE A 167 ASP A 168 SITE 3 AC2 28 ALA A 169 SER A 215 LEU A 216 ALA A 217 SITE 4 AC2 28 ASN A 218 LEU A 265 THR A 266 TYR A 267 SITE 5 AC2 28 LYS A 285 GLY A 313 PRO A 314 LEU A 315 SITE 6 AC2 28 SER A 317 ALA A 319 ALA A 320 HOH A 556 SITE 7 AC2 28 HOH A 561 HOH A 570 PHE C 368 ALA C 372 CRYST1 131.899 131.899 82.845 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007582 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007582 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012071 0.00000